Literature DB >> 24055062

Characterization and analysis of the composition and dynamics of the mammalian riboproteome.

Markus Reschke1, John G Clohessy, Nina Seitzer, Daniel P Goldstein, Susanne B Breitkopf, Daniel B Schmolze, Ugo Ala, John M Asara, Andrew H Beck, Pier Paolo Pandolfi.   

Abstract

Increasing evidence points to an important role for the ribosome in the regulation of biological processes and as a target for deregulation in disease. Here, we describe a SILAC (stable isotope labeling by amino acids in cell culture)-based mass spectrometry approach to probing mammalian riboproteomes. Using a panel of cell lines, as well as genetic and pharmacological perturbations, we obtained a comparative characterization of the cellular riboproteome. This analysis identified a set of riboproteome components, consisting of a diverse array of proteins with a strong enrichment for RNA-binding proteins. Importantly, this global analysis uncovers a high incidence of genetic alterations to riboproteome components in cancer, with a distinct bias toward genetic amplification. We further validated association with polyribosomes for several riboproteome components and demonstrate that enrichment at the riboproteome can depend on cell type, genetics, or cellular stimulus. Our results have important implications for the understanding of how ribosomes function and provide a platform for uncovering regulators of translation.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24055062      PMCID: PMC3845203          DOI: 10.1016/j.celrep.2013.08.014

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  26 in total

Review 1.  Ribosomopathies: human disorders of ribosome dysfunction.

Authors:  Anupama Narla; Benjamin L Ebert
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

2.  Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.

Authors:  Yonghao Yu; Sang-Oh Yoon; George Poulogiannis; Qian Yang; Xiaoju Max Ma; Judit Villén; Neil Kubica; Gregory R Hoffman; Lewis C Cantley; Steven P Gygi; John Blenis
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

3.  Andromeda: a peptide search engine integrated into the MaxQuant environment.

Authors:  Jürgen Cox; Nadin Neuhauser; Annette Michalski; Richard A Scheltema; Jesper V Olsen; Matthias Mann
Journal:  J Proteome Res       Date:  2011-02-22       Impact factor: 4.466

4.  The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.

Authors:  Peggy P Hsu; Seong A Kang; Jonathan Rameseder; Yi Zhang; Kathleen A Ottina; Daniel Lim; Timothy R Peterson; Yongmun Choi; Nathanael S Gray; Michael B Yaffe; Jarrod A Marto; David M Sabatini
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

5.  Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.

Authors:  Michael G Kharas; Christopher J Lengner; Fatima Al-Shahrour; Lars Bullinger; Brian Ball; Samir Zaidi; Kelly Morgan; Winnie Tam; Mahnaz Paktinat; Rachel Okabe; Maricel Gozo; William Einhorn; Steven W Lane; Claudia Scholl; Stefan Fröhling; Mark Fleming; Benjamin L Ebert; D Gary Gilliland; Rudolf Jaenisch; George Q Daley
Journal:  Nat Med       Date:  2010-07-08       Impact factor: 53.440

6.  The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration.

Authors:  Carla Burrows; Normala Abd Latip; Sarah-Jane Lam; Lee Carpenter; Kirsty Sawicka; George Tzolovsky; Hani Gabra; Martin Bushell; David M Glover; Anne E Willis; Sarah P Blagden
Journal:  Nucleic Acids Res       Date:  2010-04-29       Impact factor: 16.971

Review 7.  The mechanism of eukaryotic translation initiation and principles of its regulation.

Authors:  Richard J Jackson; Christopher U T Hellen; Tatyana V Pestova
Journal:  Nat Rev Mol Cell Biol       Date:  2010-02       Impact factor: 94.444

8.  PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients.

Authors:  Iwona K Kolasa; Alina Rembiszewska; Anna Felisiak; Izabela Ziolkowska-Seta; Magdalena Murawska; Joanna Moes; Agnieszka Timorek; Agnieszka Dansonka-Mieszkowska; Jolanta Kupryjanczyk
Journal:  Cancer Biol Ther       Date:  2009-01-17       Impact factor: 4.742

9.  Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.

Authors:  Morris E Feldman; Beth Apsel; Aino Uotila; Robbie Loewith; Zachary A Knight; Davide Ruggero; Kevan M Shokat
Journal:  PLoS Biol       Date:  2009-02-10       Impact factor: 8.029

10.  The landscape of somatic copy-number alteration across human cancers.

Authors:  Rameen Beroukhim; Craig H Mermel; Dale Porter; Guo Wei; Soumya Raychaudhuri; Jerry Donovan; Jordi Barretina; Jesse S Boehm; Jennifer Dobson; Mitsuyoshi Urashima; Kevin T Mc Henry; Reid M Pinchback; Azra H Ligon; Yoon-Jae Cho; Leila Haery; Heidi Greulich; Michael Reich; Wendy Winckler; Michael S Lawrence; Barbara A Weir; Kumiko E Tanaka; Derek Y Chiang; Adam J Bass; Alice Loo; Carter Hoffman; John Prensner; Ted Liefeld; Qing Gao; Derek Yecies; Sabina Signoretti; Elizabeth Maher; Frederic J Kaye; Hidefumi Sasaki; Joel E Tepper; Jonathan A Fletcher; Josep Tabernero; José Baselga; Ming-Sound Tsao; Francesca Demichelis; Mark A Rubin; Pasi A Janne; Mark J Daly; Carmelo Nucera; Ross L Levine; Benjamin L Ebert; Stacey Gabriel; Anil K Rustgi; Cristina R Antonescu; Marc Ladanyi; Anthony Letai; Levi A Garraway; Massimo Loda; David G Beer; Lawrence D True; Aikou Okamoto; Scott L Pomeroy; Samuel Singer; Todd R Golub; Eric S Lander; Gad Getz; William R Sellers; Matthew Meyerson
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

View more
  27 in total

1.  Ribosome Mediated Quinary Interactions Modulate In-Cell Protein Activities.

Authors:  Christopher M DeMott; Subhabrata Majumder; David S Burz; Sergey Reverdatto; Alexander Shekhtman
Journal:  Biochemistry       Date:  2017-08-03       Impact factor: 3.162

2.  Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation.

Authors:  Vijaykumar Chennupati; Diogo Ft Veiga; Kendle M Maslowski; Nicola Andina; Aubry Tardivel; Eric Chi-Wang Yu; Martina Stilinovic; Cedric Simillion; Michel A Duchosal; Manfredo Quadroni; Irene Roberts; Vijay G Sankaran; H Robson MacDonald; Nicolas Fasel; Anne Angelillo-Scherrer; Pascal Schneider; Trang Hoang; Ramanjaneyulu Allam
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

3.  Biological Relevance and Therapeutic Potential of the Hypusine Modification System.

Authors:  Nora Pällmann; Melanie Braig; Henning Sievert; Michael Preukschas; Irm Hermans-Borgmeyer; Michaela Schweizer; Claus Henning Nagel; Melanie Neumann; Peter Wild; Eugenia Haralambieva; Christian Hagel; Carsten Bokemeyer; Joachim Hauber; Stefan Balabanov
Journal:  J Biol Chem       Date:  2015-06-02       Impact factor: 5.157

Review 4.  The frontier of RNA metamorphosis and ribosome signature in neocortical development.

Authors:  Matthew L Kraushar; Tatiana Popovitchenko; Nicole L Volk; Mladen-Roko Rasin
Journal:  Int J Dev Neurosci       Date:  2016-05-27       Impact factor: 2.457

5.  Elevated levels of ribosomal proteins eL36 and eL42 control expression of Hsp90 in rhabdomyosarcoma.

Authors:  Sarah Shaikho; Christine C Dobson; Thet Naing; Bahram Samanfar; Houman Moteshareie; Maryam Hajikarimloo; Ashkan Golshani; Martin Holcik
Journal:  Translation (Austin)       Date:  2016-10-04

Review 6.  Exploring ribosome composition and newly synthesized proteins through proteomics and potential biomedical applications.

Authors:  Miroslava Stastna; Roberta A Gottlieb; Jennifer E Van Eyk
Journal:  Expert Rev Proteomics       Date:  2017-05-26       Impact factor: 3.940

7.  Invariable stoichiometry of ribosomal proteins in mouse brain tissues with aging.

Authors:  Susan Amirbeigiarab; Parnian Kiani; Ana Velazquez Sanchez; Christoph Krisp; Andriy Kazantsev; Lars Fester; Hartmut Schlüter; Zoya Ignatova
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-21       Impact factor: 11.205

8.  Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis.

Authors:  Rajiv K Khajuria; Mathias Munschauer; Jacob C Ulirsch; Claudia Fiorini; Leif S Ludwig; Sean K McFarland; Nour J Abdulhay; Harrison Specht; Hasmik Keshishian; D R Mani; Marko Jovanovic; Steven R Ellis; Charles P Fulco; Jesse M Engreitz; Sabina Schütz; John Lian; Karen W Gripp; Olga K Weinberg; Geraldine S Pinkus; Lee Gehrke; Aviv Regev; Eric S Lander; Hanna T Gazda; Winston Y Lee; Vikram G Panse; Steven A Carr; Vijay G Sankaran
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

9.  Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs.

Authors:  Kyoko Ito; Keisuke Ito
Journal:  Cell Stem Cell       Date:  2015-08-06       Impact factor: 24.633

10.  Functional Dynamics within the Human Ribosome Regulate the Rate of Active Protein Synthesis.

Authors:  Angelica Ferguson; Leyi Wang; Roger B Altman; Daniel S Terry; Manuel F Juette; Benjamin J Burnett; Jose L Alejo; Randall A Dass; Matthew M Parks; C Theresa Vincent; Scott C Blanchard
Journal:  Mol Cell       Date:  2015-10-22       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.